July 16, 2018
July 22, 2019
More studies are needed to determine best strategies for reducing complications associated with blood transfusions in patients with sickle cell disease, according to a review published in Transfusion Medicine Review. The paper is authored by advisors of the REdHHoTT project (Registry and Education for Hemovigilance in Hemoglobinopathy) in Georgia. The Georgia Health Policy Center is leading REdHHoTT efforts to characterize and reduce complications associated with therapeutic blood transfusions in people with sickle cell disease and thalassemia.